Go Pro

Corvus Pharmaceuticals (CRVS) Institutional Ownership

Corvus Pharmaceuticals logo
$14.39 -0.26 (-1.77%)
As of 09/4/2026 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Corvus Pharmaceuticals (NASDAQ:CRVS)

Current
Institutional Ownership
Percentage
46.64%
Number of
Institutional Buyers
(last 12 months)
84
Total
Institutional Inflows
(last 12 months)
$351.32M
Number of
Institutional Sellers
(last 12 months)
20
Total
Institutional Outflows
(last 12 months)
$33.88M
Get CRVS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Corvus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CRVS Institutional Buying and Selling by Quarter

Corvus Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/24/2026 California State Teachers Retirement System1,059,545$15.83M0.0%+30,190.0%1.260%
8/21/2026 Braidwell LP2,126,298$31.77M1.2%+21.3%2.528%
8/20/2026 Ancora Advisors LLC56,723$847K0.0%+3.6%0.067%
8/19/2026 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC74,369$1.11M0.0%+1,116.0%0.088%
8/19/2026 Wellington Management Group LLP2,731,632$40.81M0.0%+17.8%3.247%
8/17/2026 Seven Fleet Capital Management LP82,890$1.24M0.0%N/A0.099%
8/17/2026 Bank of America Corp DE757,798$11.32M0.0%N/A0.901%
8/15/2026 Jupiter Topco LLC28,100$420K0.0%N/A0.033%
8/14/2026 ADAR1 Capital Management LLC117,101$1.75M0.1%N/A0.139%
8/14/2026 Ancora Advisors LLC56,723$847K0.0%N/A0.067%
8/14/2026 Legal & General Group Plc41,697$623K0.0%N/A0.050%
8/14/2026 The Manufacturers Life Insurance Company82,907$1.24M0.0%N/A0.099%
8/14/2026 Spruce Street Capital LP231,585$3.46M0.0%N/A0.275%
8/13/2026 Polymer Capital Management HK LTD263,662$3.94M0.2%N/A0.313%
8/13/2026 Connor Clark & Lunn Investment Management Ltd.217,750$3.25M0.0%N/A0.259%
8/11/2026 Blue Owl Capital Holdings LP608,600$9.09M1.4%N/A0.724%
8/11/2026 E Fund Management Co. Ltd.11,491$172K0.0%N/A0.014%
8/10/2026 DCF Advisers LLC637,500$9.52M1.7%N/A0.758%
8/8/2026 Meeder Asset Management Inc.6,055$90K0.0%N/A0.007%
8/7/2026 BlackRock Inc.7,138,811$106.65M0.0%N/A8.489%
8/7/2026 Deutsche Bank AG74,529$1.11M0.0%N/A0.089%
8/7/2026 Mitsubishi UFJ Asset Management Co. Ltd.3,200$48K0.0%N/A0.004%
8/7/2026 OneDigital Investment Advisors LLC10,001$149K0.0%N/A0.012%
8/7/2026 Hikari Power Ltd49,959$746K0.1%N/A0.059%
8/6/2026 Global Retirement Partners LLC2,002$30K0.0%N/A0.002%
8/6/2026 Bank of New York Mellon Corp202,609$3.03M0.0%N/A0.241%
8/6/2026 State of Wyoming4,735$71K0.0%N/A0.006%
7/10/2026 Tema ETFs LLC136,276$2.04M0.1%+26.4%0.162%
7/9/2026 Avity Investment Management Inc.37,150$555K0.0%+11.9%0.044%
6/4/2026 Seven Fleet Capital Management LP82,890$1.21M0.4%N/A0.099%
5/29/2026 Perceptive Advisors LLC2,292,441$33.54M0.7%+231.1%2.726%
5/28/2026 Avidity Partners Management LP115,000$1.68M0.3%N/A0.137%
5/20/2026 Vivo Capital LLC2,805,816$41.05M3.4%+25.6%3.337%
5/18/2026 ADAR1 Capital Management LLC87,901$1.29M0.1%-81.1%0.105%
5/16/2026 The Manufacturers Life Insurance Company101,779$1.49M0.0%+481.7%0.121%
5/16/2026 Quantinno Capital Management LP22,982$336K0.0%N/A0.027%
5/15/2026 Commodore Capital LP2,258,735$33.05M1.9%N/A2.686%
5/15/2026 Spruce Street Capital LP231,585$3.39M0.8%N/A0.275%
5/14/2026 Renaissance Technologies LLC81,310$1.19M0.0%N/A0.097%
5/14/2026 Sei Investments Co.60,848$890K0.0%N/A0.072%
Bezos… DOOMED (Ad)

A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing September 25.tc pixel

Watch James Altucher's free video breakdown before the September 25 deadline.
5/7/2026 SEB Asset Management AB226,837$3.32M0.0%N/A0.270%
5/6/2026 Towerview LLC70,000$1.02M0.7%-50.0%0.083%
5/5/2026 Bank of New York Mellon Corp185,347$2.71M0.0%+40.8%0.220%
5/4/2026 Emerald Mutual Fund Advisers Trust459,253$6.72M0.3%N/A0.546%
5/4/2026 Emerald Advisers LLC686,216$10.04M0.3%N/A0.816%
5/4/2026 Teachers Retirement System of The State of Kentucky8,000$117K0.0%N/A0.010%
4/29/2026 Shelton Wealth Management LLC12,268$179K0.1%-21.6%0.015%
4/28/2026 Whittier Trust Co. of Nevada Inc.10,200$150K0.0%-8.9%0.012%
4/27/2026 Simplify Asset Management Inc.20,242$296K0.0%N/A0.024%
4/16/2026 SG Americas Securities LLC35,420$518K0.0%+76.9%0.042%
3/20/2026 Hsbc Holdings PLC59,269$451K0.0%-28.1%0.071%
2/19/2026 Invesco Ltd.43,583$336K0.0%+12.7%0.052%
2/18/2026 Virtus Investment Advisers LLC31,783$245K0.1%+18.4%0.038%
2/18/2026 Wellington Management Group LLP314,683$2.42M0.0%+74.7%0.376%
2/18/2026 RTW Investments LP447,607$3.45M0.0%-83.3%0.534%
2/18/2026 Perceptive Advisors LLC692,441$5.33M0.1%-51.9%0.827%
2/18/2026 Millennium Management LLC688,770$5.30M0.0%N/A0.822%
2/18/2026 Bridgeway Capital Management LLC26,700$206K0.0%-60.0%0.032%
2/17/2026 Logos Global Management LP500,000$3.85M0.2%N/A0.597%
2/17/2026 ADAR1 Capital Management LLC465,875$3.59M0.3%N/A0.556%
2/17/2026 MPM Bioimpact LLC2,743,671$21.13M2.4%N/A3.275%
2/17/2026 Price T Rowe Associates Inc. MD34,105$263K0.0%+5.2%0.041%
2/17/2026 Captrust Financial Advisors11,051$85K0.0%N/A0.013%
2/17/2026 Fred Alger Management LLC144,381$1.11M0.0%N/A0.172%
2/17/2026 ExodusPoint Capital Management LP86,720$668K0.0%N/A0.104%
2/17/2026 Graham Capital Management L.P.19,274$148K0.0%N/A0.023%
2/17/2026 Foresite Capital Management VI LLC1,381,233$10.64M3.2%-20.2%1.649%
2/16/2026 Squarepoint Ops LLC104,820$807K0.0%N/A0.125%
2/16/2026 Truvestments Capital LLC10,257$79K0.0%+86.1%0.012%
2/16/2026 Verition Fund Management LLC21,382$165K0.0%N/A0.026%
2/16/2026 Barclays PLC394,766$3.04M0.0%+27.7%0.471%
2/13/2026 Marshall Wace LLP216,248$1.67M0.0%N/A0.258%
2/13/2026 The Manufacturers Life Insurance Company 17,497$135K0.0%-6.6%0.021%
2/13/2026 Rafferty Asset Management LLC99,724$768K0.0%N/A0.119%
2/13/2026 Charles Schwab Investment Management Inc.171,173$1.32M0.0%-3.7%0.204%
2/13/2026 State Street Corp2,788,223$21.47M0.0%+177.1%3.328%
2/13/2026 Wells Fargo & Company MN62,623$482K0.0%+72.1%0.075%
2/12/2026 DRW Securities LLC23,384$180K0.0%N/A0.028%
2/12/2026 MetLife Investment Management LLC30,782$237K0.0%-8.4%0.037%
2/12/2026 Alps Advisors Inc.61,318$472K0.0%N/A0.073%
2/11/2026 DCF Advisers LLC729,000$5.61M1.5%N/A0.870%
2/11/2026 Deutsche Bank AG56,039$432K0.0%+4.5%0.067%
2/11/2026 Fox Run Management L.L.C.11,220$86K0.0%N/A0.013%
2/10/2026 Goldman Sachs Group Inc.553,327$4.26M0.0%+24.2%0.661%
2/10/2026 AXQ Capital LP12,601$97K0.0%-53.4%0.015%
2/10/2026 Intech Investment Management LLC35,973$277K0.0%+37.5%0.043%
2/9/2026 Geode Capital Management LLC1,473,026$11.35M0.0%+1.1%1.758%
2/6/2026 ProShare Advisors LLC13,764$106K0.0%+7.7%0.016%
2/4/2026 Towerview LLC140,000$1.08M0.8%-17.6%0.167%
1/29/2026 China Universal Asset Management Co. Ltd.18,169$140K0.0%+39.1%0.022%
Wall Street pays $32K for this type of stock market data. (But see this Labor Day deal now!) (Ad)

The Bloomberg Terminal costs $32,000 a year and sits on the desks of more than 350,000 Wall Street traders. Most everyday investors never get that kind of access. A different stock rating system, examined in a Wall Street Journal study, outperformed Deutsche Bank, Merrill Lynch, JPMorgan Chase, and Goldman Sachs. Stocks it rates Buy have averaged a 303% gain, including winners and losers. This Labor Day weekend, get a full year of access for just $49 - an 89% discount. The offer disappears Monday at 11:59pm Eastern.tc pixel

Get the full details on this stock rating system now
1/26/2026 Shelton Wealth Management LLC15,638$120K0.1%+13.8%0.021%
1/26/2026 Mirae Asset Global Investments Co. Ltd.3,629$28K0.0%+26.0%0.005%
1/21/2026 Palumbo Wealth Management LLC26,255$202K0.0%+11.2%0.035%
1/21/2026 Sowell Financial Services LLC17,000$131K0.0%+41.7%0.023%
1/16/2026 Tema Etfs LLC79,698$614K0.0%+34.6%0.107%
1/16/2026 Empirical Financial Services LLC d.b.a. Empirical Wealth Management167,400$1.29M0.0%-1.1%0.224%
1/9/2026 SG Americas Securities LLC20,021$154K0.0%N/A0.027%
1/1/2026 JPMorgan Chase & Co.32,232$238K0.0%+6.0%0.043%
11/17/2025 Quarry LP3,653$27K0.0%N/A0.005%
11/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.27,525$203K0.0%-4.0%0.037%


CRVS Institutional Ownership - Frequently Asked Questions

During the previous two years, 132 institutional investors and hedge funds held shares of Corvus Pharmaceuticals. The most heavily invested institutionals were BlackRock Inc. ($106.65M), Vivo Capital LLC ($41.05M), Wellington Management Group LLP ($40.81M), Perceptive Advisors LLC ($33.54M), Commodore Capital LP ($33.05M), Braidwell LP ($31.77M), and Orbimed Advisors LLC ($28.66M).Learn more on Corvus Pharmaceuticals' institutional investors.

46.64% of Corvus Pharmaceuticals' stock is owned by institutional investors. Learn more on CRVS's institutional investor holdings.

Of the 123 institutional investors that purchased Corvus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($7.14M), Perceptive Advisors LLC ($3.04M), MPM Bioimpact LLC ($2.74M), RTW Investments LP ($2.68M), Commodore Capital LP ($2.26M), State Street Corp ($1.84M), and Foresite Capital Management VI LLC ($1.73M).

Institutional investors have bought a total of 27,907,268 shares in the last 24 months. This purchase volume represents approximately $351.32M in transactions.

Of the 20 institutional investors that sold Corvus Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: RTW Investments LP ($2.23M), Perceptive Advisors LLC ($746.15K), ADAR1 Capital Management LLC ($377.97K), Foresite Capital Management VI LLC ($350K), Towerview LLC ($100K), Bridgeway Capital Management LLC ($40K), and Barclays PLC ($34.37K).

Institutional investors have sold a total of 3,996,884 shares in the last 24 months. This volume of shares sold represents approximately $33.88M in transactions.



Institutional ownership data for NASDAQ:CRVS is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/24/2026. New 13F filings are added each quarter as they're published.
From Our Partners